Polaryx Therapeutics, Inc. (PLYX)

Polaryx Therapeutics will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Polaryx Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Selling, General & Admin	-	1.54	1.01
Research & Development	-	2.81	2.77
Operating Expenses	-	4.35	3.78
Operating Income	-7.63	-4.35	-3.78
Other Expense / Income	0.58	26	-0
Pretax Income	-8.21	-30.36	-3.78
Net Income	-8.21	-30.36	-3.78
Free Cash Flow	-3.31	-2.57	-0.17
EBITDA	-8.21	-30.36	-3.78
EBIT	-8.21	-30.36	-3.78

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).